Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q2)Dec 31, 2025 | (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -4,490.75%-1.82M | -640.97%-160.14K | -352.71%-433.55K | -1,313.73%-556.03K | -78.41%51.54K | 128.13%41.34K | -13.03%29.6K | 47.16%171.56K | 45.81K | 238.67K |
| Net income from continuing operations | -536.70%-1.03M | 875.20%289.48K | -1,293.37%-1.18M | -2,753.65%-744.15K | -848.32%-631.96K | 273.18%235.53K | -440.41%-37.34K | 38.09%-84.54K | ---26.08K | --84.45K |
| Operating gains losses | ---180K | ---120K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 311.49%185.05K | 92.34%113.97K | 27.66%245.38K | 62.75%80.97K | --60.18K | --44.97K | 37.92%59.25K | -9.45%192.21K | --49.75K | ---- |
| Asset impairment expenditure | ---- | ---- | --8.45K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | ---60K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | --269.6K | --205.42K | 535.15%64.18K | ---- | ---- | --0 | --0 | ---14.75K |
| Other non cashItems | 727.23%33.81K | -3,922.77%-435.57K | 1,938.26%492.26K | 2,634.57%171.81K | --304.97K | --4.09K | 114.86%11.39K | 5.49%24.15K | --6.28K | ---- |
| Change In working capital | -5,518.96%-1.45M | -116.48%-8.01K | -631.79%-211.32K | -1,478.36%-218.54K | -283.36%-15.84K | 18.57%26.75K | 49.42%-3.7K | 121.32%39.74K | --15.86K | --8.64K |
| -Change in receivables | -1,123.98%-125.36K | -10,947.23%-54.89K | 94.46%-1.02K | 91.74%-330 | 147.66%9.04K | -198.64%-10.24K | 108.60%506 | -734.20%-18.47K | ---4K | ---18.98K |
| -Change in prepaid assets | ---90.61K | --78.91K | ---135.05K | ---127.18K | 56.64%-7.87K | --0 | --0 | --0 | --0 | ---18.15K |
| -Change in payables and accrued expense | -3,385.16%-1.22M | -16,746.17%-78.24K | -251.43%-84.19K | -668.29%-104.65K | -138.15%-17.01K | 582.35%37K | 78.03%470 | 264.71%55.6K | --18.41K | --44.59K |
| -Change in other working capital | ---18.45K | 1,087.79%46.2K | 242.74%8.94K | 848.40%13.62K | --0 | --0 | -175.12%-4.68K | 197.13%2.61K | --1.44K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -4,490.75%-1.82M | -640.97%-160.14K | -352.71%-433.55K | -1,313.73%-556.03K | -78.41%51.54K | 128.13%41.34K | -13.03%29.6K | 47.16%171.56K | --45.81K | --238.67K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1.18M | -220.51K | 3,188.45%434.98K | 4,465.94%204.98K | 1,373.30%230K | 0 | 0 | -14.08K | -4.7K | 15.61K |
| Net PPE purchase and sale | ---13.07K | ---80.38K | -137.82%-33.5K | 709.71%28.63K | ---62.12K | --0 | --0 | ---14.08K | ---4.7K | ---- |
| Net business purchase and sale | ---1.19M | ---140.13K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net other investing changes | ---- | ---- | --468.47K | --176.36K | --467.12K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---1.18M | ---220.51K | 3,188.45%434.98K | 4,465.94%204.98K | 1,373.30%230K | --0 | --0 | ---14.08K | ---4.7K | --15.61K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13,672.53%5.62M | -18.81%-46.95K | 700.79%940.23K | 2,504.81%925.44K | 131.14%95.7K | -117.97%-41.4K | 3.74%-39.51K | -53.70%-156.5K | -38.48K | -307.31K |
| Net issuance payments of debt | 1,864.66%714.9K | -5.78%-61.89K | 5.65%-172.77K | 50.44%-23.97K | ---49.78K | ---40.51K | -53.79%-58.51K | 3.78%-183.13K | ---48.36K | ---- |
| Net common stock issuance | --4.9M | --14.95K | --1.26M | --1.01M | 197.84%244.59K | --0 | --0 | --0 | --0 | ---250K |
| Net other financing activities | ---- | ---- | -639.39%-143.64K | -734.19%-62.64K | -227.95%-99.11K | 98.46%-889 | 733.33%19K | -69.91%26.63K | --9.88K | --77.46K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 13,672.53%5.62M | -18.81%-46.95K | 700.79%940.23K | 2,504.81%925.44K | 131.14%95.7K | -117.97%-41.4K | 3.74%-39.51K | -53.70%-156.5K | ---38.48K | ---307.31K |
| Net cash flow | ||||||||||
| Beginning cash position | 3,169.56%514.14K | 3,673.33%967.29K | 3.98%25.64K | 1,608.19%392.9K | -98.48%15.67K | -10.87%15.73K | 3.98%25.64K | 149.12%24.65K | --23K | --1.03M |
| Current changes in cash | 4,366,898.33%2.62M | -4,214.76%-427.59K | 95,791.75%941.66K | 21,706.83%574.39K | 811.37%377.24K | -100.10%-60 | -41.35%-9.91K | -93.35%982 | --2.63K | ---53.03K |
| Effect of exchange rate changes | ---35.23K | ---25.56K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| End cash Position | 19,682.89%3.1M | 3,169.56%514.14K | 3,673.33%967.29K | 3,673.33%967.29K | 1,608.19%392.9K | -98.48%15.67K | -10.87%15.73K | 3.98%25.64K | --25.64K | --23K |
| Free cash from | -4,522.37%-1.83M | -912.49%-240.51K | -396.57%-467.05K | -1,382.70%-527.41K | -104.62%-10.58K | 128.13%41.34K | -13.03%29.6K | 35.08%157.48K | --41.12K | --229.28K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.